StockData
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. (SRPT) stock

SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.77−0.36 (-2.38%)

Close on Nov 17, 2026Market cap $1.56BP/E –Yield –

Sarepta Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Sarepta Therapeutics's market cap was $1.76B on Nov 11, 2026, against $2.24B a year earlier. Over the last 5 years it ranged from $1.57B to $14.93B, with a median of $8.13B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.76B-21.9%
2025Dec 31, 2025$2.25B-80.6%
2024Dec 31, 2024$11.61B+28.7%
2023Dec 29, 2023$9.02B-20.7%
2022Dec 30, 2022$11.37B+57.9%
2021Dec 31, 2021$7.20B-46.4%
2020Dec 31, 2020$13.43B+39.7%
2019Dec 31, 2019$9.61B+32.1%
2018Dec 31, 2018$7.28B+102.6%
2017Dec 29, 2017$3.59B+141.0%
2016Dec 30, 2016$1.49B-7.9%
2015Dec 31, 2015$1.62B+170.9%
2014Dec 31, 2014$597.68M-21.8%
2013Dec 31, 2013$764.56M+31.0%
2012Dec 31, 2012$583.70M+473.4%
2011Dec 30, 2011$101.80M-48.4%
2010Dec 31, 2010$197.35M–

More Sarepta Therapeutics figures

See a number that looks wrong?